rfhg_230844.1

Basic information about the TSS

---

TSS ID: rfhg_230844.1 Species: human Chr: chr22		Start: 41833492 End: 41833514 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AB463291:-221 GeneID: 6721 HGNC/MGI_ID: HGNC:11290 UniProt_ID: Nearer transcript ids and distances: CU013472:-223 CU013184:-223 AK299914:-242 CT841522:-303 ENST00000424354.5:-328 BC051385:-328 U02031:-338 BC056158:-347 BC051799:-379 ENST00000361204.9:-387 NM_004599.4:-387 NR_103834.2:-387 ENST00000612482.4:-413 view more...

Gene_name: sterol regulatory element binding transcription factor 2 Gene_symbol: SREBF2 Gene_synonyms: SREBP2 bHLHd2 Gene_source: HGNC:11290

TATA-Box annotation

---

Distance to TSS:	398
Nearest PromoterID:	NR_103834
Entrez ID:	6721
Nearest Unigene:	Hs.443258
Nearest Refseq:	NM_004599
Nearest Ensembl:	ENSG00000198911
Gene Name:	sterol regulatory element binding transcription factor 2
Gene Alias:	SREBP-2|SREBP2|bHLHd2
Gene Type:	protein-coding
CpG%:	0.136364
GC%:	0.739130
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SREBF2 p2@SREBF2 p3@SREBF2 p4@SREBF2
Sample		p1@SREBF2	p2@SREBF2	p3@SREBF2	p4@SREBF2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	55.91	17.92	2.53	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	55.03	12.95	2.23	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	51.12	16.78	0.96	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	41.58	9.36	2.08	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	46.79	11.25	1.57	1.12
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	38.57	9.88	0.58	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.67	6.97	0.65	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	38.27	10.90	0.97	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.11	9.83	1.07	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	59.12	9.85	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	47.30	6.06	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	51.63	10.16	0.81	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	38.85	3.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	38.34	2.10	0.00	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	30.74	2.85	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	32.44	3.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	35.60	2.40	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.68	2.11	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	27.68	1.65	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.08	1.47	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	34.70	2.42	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.18	1.94	0.13	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.40	1.70	0.24	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.15	3.10	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	25.32	1.90	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.92	2.20	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	40.79	4.95	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	23.74	1.13	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	30.95	1.81	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.24	4.19	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.80	2.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.12	3.59	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	24.08	3.46	0.33	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	29.17	2.99	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	23.57	2.68	0.38	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.98	4.09	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	26.80	4.63	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	30.52	4.86	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	25.69	3.36	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.76	2.82	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.45	3.07	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.78	2.11	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.11	2.80	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	22.89	3.01	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	22.10	3.72	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	23.99	3.60	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.48	2.68	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.74	2.87	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.80	2.63	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.06	2.87	0.00	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	28.69	2.89	0.22	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.78	4.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.19	3.98	0.33	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	16.78	1.68	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.26	2.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.01	3.24	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.63	1.28	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	27.35	2.51	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	2.82	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	34.77	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.88	0.80	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.44	2.72	0.00	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.92	4.87	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	49.34	6.39	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	71.18	16.58	0.49	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	74.38	17.85	1.98	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	82.09	19.70	1.41	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	61.93	17.22	0.33	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	76.10	19.80	2.17	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	74.60	16.51	0.92	0.92
Adipocyte - breast, donor1	11376-118A8	66.05	8.55	1.43	0.16
Adipocyte - breast, donor2	11327-117E4	66.74	10.59	1.60	2.73
Adipocyte - omental, donor1	11473-119C6	96.95	9.80	2.54	0.76
Adipocyte - omental, donor2	11474-119C7	65.03	6.73	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	87.08	12.06	2.01	2.34
Adipocyte - perirenal, donor1	11476-119C9	80.39	12.12	1.28	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	35.18	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	70.91	3.61	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	81.85	5.39	0.52	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	165.06	24.25	4.50	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	118.65	13.90	1.80	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	177.02	34.85	4.46	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	148.13	41.15	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	139.39	33.78	5.15	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	144.27	27.11	4.20	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	108.77	35.72	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	104.61	23.37	5.01	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	80.68	14.97	2.08	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	116.79	27.63	6.53	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	89.67	15.71	2.62	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	86.17	11.27	3.65	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	82.21	10.17	1.55	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	128.37	29.76	6.10	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	85.06	11.98	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	134.03	30.40	3.42	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	113.80	13.39	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	99.03	24.04	3.08	0.62
Anulus Pulposus Cell, donor1	11248-116E6	112.60	11.10	1.60	1.03
Anulus Pulposus Cell, donor2	11463-119B5	75.19	7.84	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	57.96	6.74	1.80	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	70.76	3.04	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	0.00	0.00	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	55.90	4.18	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	45.53	6.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	43.56	5.94	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	49.38	2.92	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	52.91	2.91	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	38.60	4.75	0.00	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	48.59	5.27	1.88	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	50.80	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	3.76	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	42.01	1.98	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	61.42	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.18	2.26	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	49.83	7.50	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	46.86	5.10	0.76	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.09	4.28	0.53	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	48.77	3.90	1.95	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	46.61	4.48	1.16	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	3.60	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	84.96	14.16	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	53.35	4.46	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	50.48	2.43	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	54.26	5.69	0.76	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	30.28	3.63	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	51.30	6.84	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	44.04	5.34	1.07	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	37.68	5.42	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	48.80	5.63	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	50.80	4.18	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	32.82	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	38.61	4.68	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	42.75	4.22	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	43.96	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	53.91	3.56	0.51	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	41.51	4.08	0.25	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.76	2.54	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	49.19	4.32	0.43	1.29
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	40.22	2.12	1.06	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.39	2.90	0.58	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	57.63	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	37.30	3.22	0.34	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	80.28	10.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	49.74	2.57	0.64	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	37.90	4.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	37.91	5.83	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	49.19	3.68	1.15	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	51.01	10.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	18.56	1.02	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	49.55	2.89	0.21	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	35.50	3.06	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	58.80	7.65	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	44.35	3.33	0.67	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	55.39	4.43	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.10	2.38	0.79	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.35	1.45	0.36	1.82
Astrocyte - cerebellum, donor1	11500-119F6	213.58	29.48	4.42	0.37
Astrocyte - cerebellum, donor2	11580-120F5	150.45	20.03	2.05	1.54
Astrocyte - cerebellum, donor3	11661-122F5	168.85	13.84	2.52	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	144.31	25.45	2.44	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	112.11	26.37	1.94	2.75
Astrocyte - cerebral cortex, donor3	11392-118C6	144.24	33.26	3.43	2.24
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	202.08	23.40	3.90	2.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	188.67	17.04	2.38	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	176.61	17.30	2.50	1.48
Basophils, donor1	12241-129G9	34.78	1.83	0.00	0.26
Basophils, donor2	12242-129H1	54.12	5.77	0.36	0.00
Basophils, donor3	12243-129H2	65.12	3.53	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	137.34	60.37	14.66	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	193.39	56.23	17.37	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	28.69	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	78.46	16.32	6.90	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	141.82	24.33	5.41	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	130.57	35.00	4.84	2.76
Bronchial Epithelial Cell, donor7	11769-123I5	101.31	30.59	5.04	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	179.32	33.29	4.43	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	228.01	45.42	6.75	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.30	2.88	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	74.39	3.94	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	78.88	6.12	0.74	0.56
CD14+ Monocytes, donor3	11381-118B4	62.35	2.85	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	99.07	4.81	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	106.52	3.79	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	106.84	5.92	0.99	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	45.97	3.47	0.00	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	30.17	3.02	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	44.30	4.03	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	43.02	3.68	0.50	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.64	3.04	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	39.92	4.71	0.99	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.83	1.76	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.73	1.96	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.33	2.61	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	44.95	1.64	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	39.07	3.17	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	51.03	4.44	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	40.91	2.68	0.45	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	28.73	2.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	23.53	1.87	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	52.16	5.03	0.46	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	34.16	2.26	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	28.81	2.18	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	34.97	3.50	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	32.10	2.79	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	39.98	3.79	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	53.46	4.41	0.37	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	35.23	5.99	1.06	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	42.12	3.51	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	34.00	3.84	0.70	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	30.85	0.74	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.72	2.59	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.15	5.73	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	36.39	0.93	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	35.26	3.48	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	28.55	1.96	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	36.27	2.54	0.00	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	22.74	0.87	0.22	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	58.40	3.58	0.31	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	33.36	1.57	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	61.99	2.90	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	21.95	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	30.30	1.54	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	19.37	0.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	87.39	8.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	101.02	16.27	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	100.45	8.28	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	78.36	12.79	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	82.02	9.11	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	81.42	7.02	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	112.16	8.63	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	71.19	17.14	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	166.85	23.84	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	216.90	37.72	2.18	2.90
CD19+ B Cells, donor3	11705-123B4	173.66	20.70	3.53	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	74.75	56.97	11.31	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	61.12	47.94	5.59	0.40
CD34+ Progenitors, donor1	11545-120B6	73.30	8.03	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	73.04	8.99	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	63.13	6.01	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.50	4.74	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	108.19	4.64	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	94.30	6.74	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	82.35	6.40	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	93.42	6.38	1.02	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	82.65	4.94	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	79.34	4.89	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	78.23	4.27	0.47	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	63.91	5.62	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	52.74	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	80.64	8.82	0.14	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.84	5.42	1.19	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	53.84	5.96	0.00	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	48.86	3.59	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	51.01	4.54	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	49.72	3.52	0.44	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	130.29	10.12	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	86.43	3.95	0.42	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	85.20	6.68	0.67	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	81.85	5.44	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	57.35	2.68	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	78.90	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	131.84	7.60	1.30	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	79.50	6.28	0.65	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	91.21	4.62	0.63	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	75.34	3.54	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	56.32	2.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	64.94	4.36	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	58.39	3.96	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	55.39	3.69	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	84.46	5.26	0.00	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	93.49	8.10	0.98	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.04	3.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	4.15	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	129.32	8.51	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	93.86	7.88	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	91.91	6.06	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	89.92	10.09	2.06	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	88.67	8.87	3.35	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	108.89	10.40	0.55	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	57.64	15.61	1.20	3.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	102.95	11.04	0.96	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	102.32	10.91	2.73	3.18
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	95.61	10.21	1.96	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	92.65	8.95	2.11	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	94.04	14.77	3.05	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	117.73	14.79	2.72	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	91.80	12.78	2.91	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	94.85	18.38	4.53	2.40
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	126.51	19.70	4.38	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	122.97	17.31	2.73	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	115.61	24.61	4.48	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	115.61	10.80	1.80	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	106.46	10.36	1.44	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	95.69	9.43	2.12	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	114.09	12.36	1.90	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	87.66	12.61	1.85	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	105.15	12.18	1.28	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	102.12	15.30	3.44	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	94.98	10.25	1.97	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	82.45	10.59	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	142.12	15.26	0.80	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	128.69	14.69	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	163.29	15.03	3.01	2.00
Cardiac Myocyte, donor1	11525-119I4	69.45	9.14	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	63.74	5.93	1.48	0.49
Cardiac Myocyte, donor3	11686-122I3	81.66	7.47	0.74	0.21
Chondrocyte - de diff, donor1	11261-116G1	23.92	2.43	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	31.63	2.49	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	29.47	2.05	0.11	0.23
Chondrocyte - re diff, donor2	11339-117F7	62.67	5.37	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	51.76	4.85	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	215.86	29.15	2.98	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	121.42	22.45	3.42	2.35
Ciliary Epithelial Cells, donor3	11399-118D4	135.49	25.49	2.74	1.86
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	134.25	15.41	1.74	0.55
Corneal Epithelial Cells, donor1	11526-119I5	188.83	34.91	5.05	0.66
Corneal Epithelial Cells, donor2	11606-120I4	134.24	45.50	14.79	3.41
Corneal Epithelial Cells, donor3	11687-122I4	128.07	18.15	5.11	1.53
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	81.56	3.96	1.98	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	77.28	4.73	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	20.70	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	88.77	7.02	1.84	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	132.22	5.12	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	79.65	3.92	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	84.69	5.81	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	95.06	9.17	1.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	48.70	3.52	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	112.55	17.25	3.68	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	74.31	8.65	2.36	0.00
Endothelial Cells - Artery, donor1	11264-116G4	34.90	3.49	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	69.17	6.35	0.47	1.18
Endothelial Cells - Artery, donor3	11413-118E9	73.45	4.91	0.70	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	104.84	10.42	1.33	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	102.23	9.74	1.83	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	112.20	11.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	99.24	14.26	2.38	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	38.01	1.56	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	83.09	8.37	0.71	1.56
Endothelial Cells - Thoracic, donor1	11266-116G6	64.82	5.20	2.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	38.26	2.10	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	162.51	16.65	1.37	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	134.92	12.60	1.09	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	134.83	14.53	1.59	0.12
Endothelial Cells - Vein, donor1	11267-116G7	70.53	14.79	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	104.78	16.76	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	84.31	7.69	0.94	0.63
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	128.03	47.64	8.31	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	91.53	54.08	8.32	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	49.26	6.57	2.05	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	33.39	4.16	1.09	0.66
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.64	1.84	0.11	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	54.45	6.67	0.97	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	51.45	6.69	0.82	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	74.46	7.38	1.37	1.79
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	81.16	23.19	5.27	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.79	9.97	1.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	53.07	9.07	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	68.97	9.85	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	62.46	6.31	2.21	1.26
Fibroblast - Cardiac, donor4	11452-119A3	109.73	15.16	2.42	0.30
Fibroblast - Cardiac, donor5	11456-119A7	99.37	11.29	1.27	2.03
Fibroblast - Cardiac, donor6	11460-119B2	81.25	13.80	2.58	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	199.78	27.87	4.56	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	106.13	11.65	2.16	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	120.11	14.65	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	222.80	29.52	2.77	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	177.41	23.58	3.56	1.19
Fibroblast - Dermal, donor1	11269-116G9	66.21	7.04	1.41	0.47
Fibroblast - Dermal, donor2	11346-117G5	79.71	6.60	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	83.53	9.43	1.45	0.97
Fibroblast - Dermal, donor4	11450-119A1	111.80	20.24	1.92	2.26
Fibroblast - Dermal, donor5	11454-119A5	84.44	19.54	2.09	1.57
Fibroblast - Dermal, donor6	11458-119A9	98.75	19.82	3.90	1.14
Fibroblast - Gingival, donor1	11237-116D4	113.90	16.45	2.08	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	56.33	6.29	0.52	0.26
Fibroblast - Gingival, donor2	11318-117D4	118.47	18.85	1.71	1.32
Fibroblast - Gingival, donor3	11394-118C8	135.36	16.34	1.35	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	117.39	9.35	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	77.35	11.45	1.23	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	64.23	4.83	1.40	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	64.23	7.84	1.49	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	137.98	10.94	4.59	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	69.32	10.53	2.05	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	57.40	5.45	1.50	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.52	6.58	0.44	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	80.41	10.71	1.76	0.44
Fibroblast - Lung, donor1	11270-116H1	133.22	27.19	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	102.96	16.41	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	110.37	13.08	1.48	0.63
Fibroblast - Lymphatic, donor1	11506-119G3	308.22	71.64	8.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	130.07	32.17	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	130.42	20.71	3.36	1.12
Fibroblast - Mammary, donor1	11540-120B1	229.37	28.01	3.65	0.41
Fibroblast - Mammary, donor2	11620-122A9	175.75	11.98	7.99	7.99
Fibroblast - Mammary, donor3	11701-123A9	131.04	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	135.39	17.46	1.75	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	162.75	28.52	2.88	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	119.64	20.20	4.28	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	88.92	18.32	4.20	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	66.15	9.99	2.43	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	80.83	9.63	1.62	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.56	4.53	1.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	242.41	48.97	7.31	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	148.34	22.05	2.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	80.26	13.05	1.98	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	60.53	14.29	1.79	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	55.42	3.37	1.42	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	56.76	3.74	0.39	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	64.08	7.52	1.50	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	80.21	6.05	1.30	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	46.06	8.86	1.27	0.51
Fibroblast - skin normal, donor1	11553-120C5	78.10	6.07	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	55.74	8.42	1.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	57.87	5.32	1.41	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	48.36	12.09	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	72.74	3.89	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	102.57	6.33	0.68	1.54
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	66.34	10.18	2.30	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	51.88	4.47	0.85	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	44.19	3.37	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	30.42	3.14	0.16	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	81.92	24.40	10.46	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	79.57	16.82	6.24	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	93.43	20.56	5.20	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	96.58	19.93	5.11	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	83.45	17.61	1.53	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	88.05	16.59	3.19	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	118.38	17.97	0.86	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	90.45	8.27	1.10	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	97.27	14.38	1.14	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	113.33	15.65	1.59	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	75.34	10.31	0.53	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	134.70	26.09	2.28	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	101.27	9.29	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	130.58	20.63	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	123.51	15.39	1.85	1.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	83.01	18.80	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	140.25	11.89	0.99	2.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	161.68	14.81	1.38	1.38
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	104.29	13.01	1.42	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	135.54	11.87	0.68	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	134.78	12.08	1.12	1.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	148.19	16.83	0.44	2.19
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	130.31	11.52	0.59	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	150.69	13.03	1.75	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	126.68	12.51	0.45	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	146.39	13.51	0.40	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	152.17	14.76	1.87	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	165.64	21.64	2.13	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	267.74	20.71	1.14	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	230.21	18.96	0.85	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	175.39	12.39	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	158.41	16.22	0.92	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	145.58	17.36	1.23	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	176.39	16.30	0.41	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	194.04	16.37	0.81	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	161.43	15.51	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	160.91	13.01	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	167.64	15.62	0.98	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	166.31	18.96	0.81	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	202.69	14.11	1.28	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	143.74	10.42	0.47	1.71
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	144.26	9.02	1.11	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	135.32	10.34	0.61	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	127.33	8.78	0.31	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	138.76	10.98	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	142.80	16.27	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	134.99	10.46	0.93	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	121.94	13.10	1.07	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	119.50	11.02	0.92	1.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	118.91	10.36	1.42	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	139.06	11.11	0.81	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	134.39	12.35	0.55	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	132.46	11.40	1.10	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	202.32	12.89	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	138.38	12.80	0.53	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	141.03	15.94	0.81	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	252.38	8.90	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	158.65	28.07	2.39	1.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	135.28	18.49	1.39	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	165.30	32.32	2.86	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	80.42	25.35	1.25	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	75.72	14.98	1.70	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	99.62	25.37	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	91.57	7.42	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	88.97	25.53	1.93	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	68.99	25.67	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	99.11	22.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	88.20	24.41	1.95	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	107.07	26.36	3.29	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	133.29	16.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	94.80	26.29	1.96	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	99.36	26.15	1.96	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	119.95	28.52	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	136.13	25.13	2.23	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	113.45	32.61	3.40	3.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	119.02	25.06	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	144.89	26.34	1.72	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	130.53	26.93	1.48	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	89.79	25.41	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	145.80	33.97	6.63	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	139.00	44.41	2.99	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	36.88	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	135.31	26.14	1.54	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	118.33	25.43	2.61	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	92.30	12.71	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	172.60	30.44	1.93	4.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	157.48	26.70	3.42	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	191.33	19.88	0.00	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	153.35	35.86	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	176.22	27.16	2.41	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	157.69	22.38	2.03	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	165.12	28.32	1.20	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	179.09	37.99	1.97	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	141.65	34.23	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	130.11	32.67	1.17	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	231.73	41.69	1.32	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	133.94	28.82	0.85	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	112.82	33.43	1.79	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	113.55	25.72	1.94	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	70.76	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	93.97	8.32	2.49	1.66
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	80.96	11.24	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	88.49	5.71	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	81.46	7.52	2.92	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	85.76	23.67	8.47	2.55
Hep-2 cells mock treated, biol_rep2	11899-125E9	84.23	25.66	10.80	3.38
Hep-2 cells mock treated, biol_rep3	11900-125F1	82.36	30.03	9.56	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	76.19	22.08	7.11	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	76.51	22.35	9.46	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	85.25	23.47	8.40	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	68.12	19.80	6.85	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	64.33	21.27	7.55	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	69.20	21.79	7.37	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	137.11	25.74	4.48	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	131.14	15.15	3.46	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	60.81	10.58	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	172.83	20.11	5.29	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	170.00	17.44	5.09	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	60.14	15.56	3.32	1.92
Hepatocyte, donor1	11523-119I2	81.11	107.74	19.37	0.00
Hepatocyte, donor2	11603-120I1	117.43	51.71	5.39	2.15
Hepatocyte, donor3	11684-122I1	80.99	61.35	12.88	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	182.75	22.19	2.61	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	131.09	38.80	3.50	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	92.48	11.53	2.06	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	111.44	50.94	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	160.21	53.40	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	54.17	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	89.98	34.61	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	135.14	27.53	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	94.95	35.60	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	151.21	30.75	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	146.26	36.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	160.81	47.11	3.25	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	93.37	38.35	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	119.81	32.68	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	125.73	48.97	5.29	10.59
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	94.23	39.91	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	136.20	41.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	92.59	34.64	2.52	5.04
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	109.81	23.20	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	14.63	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	113.70	33.59	1.29	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	123.96	56.35	6.44	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	47.79	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	132.01	42.37	4.89	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	127.62	53.74	4.20	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	28.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	109.30	47.42	3.21	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	91.40	30.47	5.54	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	76.94	25.02	3.30	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	85.26	18.14	11.79	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	58.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	117.30	34.44	2.15	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	100.37	39.38	6.35	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	123.07	49.10	4.46	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	96.60	21.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	109.97	34.28	4.28	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	82.96	39.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	82.41	18.21	1.85	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	89.56	29.85	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	25.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	97.35	15.30	0.70	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	208.03	28.77	2.21	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	129.68	38.90	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	171.77	27.03	2.62	3.49
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	161.98	38.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	118.48	38.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	193.09	22.40	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	130.23	36.02	5.54	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	102.59	39.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	139.90	37.74	6.44	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	196.65	18.15	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	229.72	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	200.90	24.32	2.11	1.06
Keratinocyte - epidermal, donor1	11272-116H3	132.19	15.75	4.73	0.82
Keratinocyte - epidermal, donor2	11349-117G8	109.51	16.40	2.34	0.59
Keratinocyte - epidermal, donor3	11421-118F8	110.75	13.16	2.08	1.04
Keratinocyte - oral, donor1	11251-116E9	195.25	31.33	2.61	1.14
Keratocytes, donor1	11527-119I6	142.69	13.41	1.03	0.00
Keratocytes, donor2	11607-120I5	133.59	16.41	1.17	0.00
Keratocytes, donor3	11688-122I5	74.10	6.13	0.99	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	287.93	46.16	8.79	0.00
Lens Epithelial Cells, donor1	11529-119I8	99.24	9.71	1.08	6.47
Lens Epithelial Cells, donor2	11609-120I7	196.41	25.37	3.58	0.46
Lens Epithelial Cells, donor3	11690-122I7	90.52	13.22	1.82	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	89.29	10.20	1.42	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	52.75	6.98	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	81.07	10.23	1.10	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	64.53	11.83	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	75.95	6.62	1.89	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	74.18	7.98	0.86	1.83
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	68.13	11.90	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	74.83	11.12	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	87.69	9.71	1.27	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	55.77	7.91	1.98	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	68.44	7.76	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	78.13	9.07	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	70.03	10.80	1.05	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	70.36	9.30	0.95	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	79.25	10.03	1.10	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	64.36	9.24	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	52.68	6.86	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	93.69	10.43	0.73	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	67.80	12.51	1.97	1.32
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	82.30	8.79	1.46	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	90.36	13.19	1.00	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	80.02	13.09	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	65.17	4.04	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	80.38	8.48	0.45	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	59.10	8.29	0.52	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	63.65	6.91	1.05	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	83.61	11.58	0.60	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	67.41	7.57	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	63.41	11.29	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	82.70	9.97	0.85	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	54.27	7.75	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	57.23	6.28	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	88.46	11.15	0.87	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	79.60	12.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	54.85	6.42	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	88.82	10.17	0.55	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	81.05	11.58	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	66.95	6.09	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	79.22	11.20	0.84	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	72.18	9.24	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	60.60	9.21	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	79.67	9.18	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	59.09	9.67	1.07	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	59.78	8.82	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	73.69	7.06	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	82.29	9.53	1.11	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	56.86	5.63	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	65.94	7.46	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	47.59	18.13	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.86	16.88	3.07	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.21	14.84	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	48.24	17.77	4.23	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	52.05	11.96	3.52	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.03	17.75	0.00	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.34	19.06	2.06	5.15
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	55.90	19.03	3.57	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	50.21	16.74	2.26	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	39.84	17.45	0.58	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	40.07	15.76	2.25	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	74.92	23.17	2.57	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	52.38	23.11	1.54	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	49.05	15.88	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	44.64	19.32	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	49.41	21.90	2.04	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	46.96	16.28	1.60	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	53.85	20.78	2.27	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	51.54	20.25	2.45	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	60.34	34.25	3.26	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	54.98	19.57	2.50	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	47.08	19.06	1.68	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	54.61	21.64	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.29	21.19	1.74	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	38.56	14.95	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	50.35	16.04	2.77	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	66.46	24.04	3.53	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	44.25	12.17	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	21.87	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	50.27	20.72	3.45	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.86	15.85	2.83	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	58.25	13.95	2.46	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	57.84	27.56	3.62	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	47.40	17.24	3.59	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	45.56	17.18	2.24	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	66.14	26.38	3.72	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.35	18.09	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	59.94	17.98	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	56.97	21.99	3.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	64.55	17.50	2.41	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	49.77	17.77	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	52.93	23.03	2.06	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.99	22.01	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	50.50	27.61	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	63.71	26.67	2.22	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	56.98	11.63	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	60.29	23.27	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	57.22	20.41	2.00	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	49.43	15.26	0.73	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	65.92	23.00	2.30	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	65.61	25.65	1.48	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.99	19.76	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	59.84	19.61	2.51	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	71.20	22.98	0.90	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	49.91	20.65	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	68.58	32.51	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	52.01	25.03	1.96	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.26	21.77	4.62	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	61.23	17.64	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	67.82	27.13	3.94	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	42.49	19.01	2.80	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	63.15	20.76	3.53	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	60.17	28.16	4.24	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.04	22.79	1.52	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.00	21.15	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	53.27	24.65	4.37	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	36.46	24.30	0.00	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.20	15.91	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	60.80	22.04	0.76	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	48.54	20.66	3.10	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.05	22.37	3.02	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	52.29	24.72	2.85	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	51.18	21.86	2.67	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	50.57	16.67	2.87	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	50.39	24.68	3.09	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	47.39	21.93	0.71	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	68.67	31.21	4.54	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.50	28.71	3.33	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	67.34	32.89	3.92	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	55.12	24.64	1.25	2.09
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	63.19	19.05	2.32	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.15	16.06	2.01	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.02	27.27	2.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.55	23.03	1.21	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	43.13	18.36	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	43.57	31.12	2.67	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	59.27	26.21	6.27	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	46.01	19.94	1.53	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	65.66	24.62	3.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	58.35	25.84	4.45	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	64.73	22.62	3.38	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	52.39	19.89	1.99	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	33.26	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	94.36	8.89	1.60	0.68
Macrophage - monocyte derived, donor2	11313-117C8	100.19	6.79	2.75	0.37
Macrophage - monocyte derived, donor3	11389-118C3	106.83	12.71	3.01	1.05
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.86	2.66	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	93.80	22.50	6.02	0.95
Mallassez-derived cells, donor3	11930-125I4	82.28	13.34	4.45	0.69
Mammary Epithelial Cell, donor1	11273-116H4	97.45	12.46	4.38	0.20
Mammary Epithelial Cell, donor2	11350-117G9	99.61	19.11	2.61	0.58
Mammary Epithelial Cell, donor3	11422-118F9	120.72	16.46	3.74	1.25
Mast cell - stimulated, donor1	11487-119E2	162.03	41.35	3.39	1.36
Mast cell, donor1	11563-120D6	228.29	22.39	3.14	0.22
Mast cell, donor2	11565-120D8	148.59	19.02	1.78	0.30
Mast cell, donor3	11566-120D9	93.20	7.65	0.45	0.00
Mast cell, donor4	11567-120E1	169.13	17.91	0.89	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	97.47	4.66	0.33	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	107.40	8.76	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	191.01	18.93	1.84	2.29
Mast cell, expanded, donor8	11941-126A6	132.22	11.55	0.17	0.33
Melanocyte - dark, donor1	11502-119F8	132.83	12.93	1.79	0.50
Melanocyte - dark, donor2	11582-120F7	76.48	7.61	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	199.79	11.23	1.81	0.65
Melanocyte - light, donor1	11274-116H5	220.50	13.40	1.65	0.24
Melanocyte - light, donor2	11351-117H1	243.64	17.06	0.00	1.36
Melanocyte - light, donor3	11423-118G1	108.40	8.67	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	177.43	14.37	1.35	3.12
Melanocyte, donor2 (MC+2)	12739-135I3	145.77	13.98	2.42	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	237.32	20.89	2.95	2.41
Meningeal Cells, donor1	11493-119E8	198.37	30.77	3.85	0.00
Meningeal Cells, donor2	11573-120E7	171.66	24.21	4.40	1.76
Meningeal Cells, donor3	11654-122E7	103.26	14.59	1.79	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	85.26	9.98	2.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	78.19	5.33	0.70	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	193.18	11.83	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	134.74	24.86	3.92	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	46.64	4.31	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	113.30	15.04	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	100.03	15.58	3.02	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	146.58	19.78	1.76	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	77.44	12.42	3.65	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	100.05	8.80	2.25	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	119.81	10.25	0.97	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	176.20	14.87	1.49	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	163.02	18.42	1.32	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	86.65	5.34	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	70.07	4.67	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	108.23	12.81	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	49.62	2.84	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	146.98	14.39	1.56	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	34.83	2.90	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	77.70	3.45	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	65.06	7.51	0.50	1.00
Mesothelial Cells, donor3	11402-118D7	94.67	9.18	1.59	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	190.40	10.80	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	130.53	12.31	2.22	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	109.54	5.89	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	172.85	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	87.40	7.44	2.17	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	84.01	6.22	2.07	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	101.91	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	114.62	9.51	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	121.96	7.91	2.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	175.20	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	105.27	9.35	1.02	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	92.66	7.13	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	136.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	84.07	15.93	2.65	4.42
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	77.89	5.70	3.42	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	140.80	3.95	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	89.98	9.76	1.49	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	83.80	2.76	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	99.85	9.84	2.38	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	105.63	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	271.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	90.33	7.28	1.76	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	83.66	8.79	1.43	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	113.34	4.98	3.32	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	82.20	9.90	1.61	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	92.97	7.36	2.73	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	86.63	8.76	1.43	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	75.95	8.15	2.15	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	90.69	6.89	3.56	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	206.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	85.20	6.79	1.75	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	110.01	8.11	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	101.08	6.63	3.31	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	87.52	10.06	2.45	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	89.40	7.94	3.53	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	82.86	5.45	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.98	5.29	1.92	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	80.05	4.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	94.61	2.74	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	61.07	7.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	81.54	6.12	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	70.07	4.82	2.19	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	91.60	4.41	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	81.33	3.20	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	67.19	6.94	1.49	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	72.37	2.78	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	114.91	4.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	78.97	9.23	1.71	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	80.96	5.69	2.19	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	102.62	4.97	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	79.68	9.54	1.68	2.52
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	70.66	5.82	2.91	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	104.31	5.24	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	88.99	12.07	4.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	79.30	2.50	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	82.20	15.70	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	89.92	5.69	2.85	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	120.63	11.33	3.87	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	94.85	8.03	2.07	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	99.95	7.29	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	95.28	6.35	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	104.62	8.27	2.40	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	106.26	9.28	2.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	99.30	7.20	1.98	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	85.04	13.70	1.59	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	82.26	11.06	2.87	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	94.04	5.69	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	103.41	12.50	1.99	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	82.34	9.34	2.46	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	98.40	7.82	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	94.97	9.70	2.94	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	108.12	11.24	5.48	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	140.95	13.19	2.89	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	109.29	9.83	2.68	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	3.77	3.77	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	3.56	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	89.70	7.89	0.66	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	70.48	9.47	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	81.25	9.49	0.99	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	2.79	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.19	2.63	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	99.61	10.39	2.66	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	59.83	4.18	0.68	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	89.14	7.37	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	87.21	6.96	0.00	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	80.89	12.44	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.57	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	65.69	3.86	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	73.73	11.11	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	34.15	2.53	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	12.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	59.89	10.34	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	102.43	17.77	3.14	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	34.04	6.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	55.51	5.84	1.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.16	6.27	0.95	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	87.77	3.19	7.98	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	2.72	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	29.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	48.97	4.19	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.27	8.37	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	66.48	13.24	1.89	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	113.95	18.08	1.89	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	67.01	11.42	1.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	61.98	4.60	1.08	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	68.46	9.07	1.59	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	74.14	6.37	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	110.26	17.50	3.28	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	61.00	7.96	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	42.62	9.60	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	61.37	5.25	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	76.27	8.29	1.46	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	155.22	22.93	3.17	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	55.56	8.44	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	66.20	5.52	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.06	4.50	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	67.94	9.31	0.69	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	106.19	10.11	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	134.12	16.26	2.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	52.50	3.81	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	72.39	6.65	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	55.80	4.29	2.58	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	74.31	7.66	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	112.72	11.27	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	50.39	3.97	1.19	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	53.86	4.64	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	64.70	7.19	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	66.15	8.80	2.28	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	49.24	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	115.79	14.02	3.62	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	54.68	8.82	3.53	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	57.18	7.31	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	52.08	4.46	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	62.78	8.42	1.53	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.46	1.81	0.60	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	114.49	13.26	2.43	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	58.96	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	31.09	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	72.39	4.72	1.57	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	24.51	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	49.84	3.16	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	89.56	3.40	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	38.64	3.23	1.12	0.99
Myoblast, donor2	11322-117D8	78.44	8.44	2.11	1.53
Myoblast, donor3	11398-118D3	65.58	6.05	1.51	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	143.74	8.32	0.58	0.15
Natural Killer Cells, donor1	11230-116C6	113.78	9.84	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	97.10	8.44	0.60	0.60
Natural Killer Cells, donor3	11387-118C1	99.02	7.36	0.18	0.37
Neural stem cells, donor1	11275-116H6	128.84	24.32	0.36	0.36
Neural stem cells, donor2	11352-117H2	302.33	94.36	3.85	1.93
Neurons, donor1	11494-119E9	154.75	46.65	3.41	2.28
Neurons, donor2	11574-120E8	167.98	18.27	2.42	0.88
Neurons, donor3	11655-122E8	105.24	32.89	3.29	5.76
Neutrophils, donor1	11233-116C9	24.13	3.71	0.00	0.00
Neutrophils, donor2	11314-117C9	34.79	5.80	0.00	5.80
Neutrophils, donor3	11390-118C4	41.54	2.44	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	118.74	7.72	0.47	0.71
Nucleus Pulposus Cell, donor2	11409-118E5	111.36	9.44	0.98	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	94.06	9.23	1.00	1.20
Olfactory epithelial cells, donor1	11933-125I7	54.37	2.62	0.28	0.69
Olfactory epithelial cells, donor2	11934-125I8	50.66	8.11	1.30	2.17
Olfactory epithelial cells, donor3	11935-125I9	50.17	5.22	0.79	0.11
Olfactory epithelial cells, donor4	11936-126A1	56.20	4.19	0.49	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	139.02	46.94	9.63	0.60
Osteoblast - differentiated, donor1	11276-116H7	77.63	2.13	0.85	0.21
Osteoblast - differentiated, donor2	11353-117H3	70.87	12.57	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	80.69	7.45	3.10	0.62
Osteoblast, donor1	11277-116H8	133.29	20.52	3.91	0.00
Osteoblast, donor2	11354-117H4	55.48	6.32	1.40	0.70
Osteoblast, donor3	11426-118G4	80.69	6.75	0.53	0.71
Pancreatic stromal cells, donor1	11249-116E7	95.19	15.42	1.60	0.84
Pericytes, donor1	11491-119E6	257.36	59.19	6.79	1.00
Pericytes, donor2	11571-120E5	220.93	41.88	4.98	3.17
Pericytes, donor3	11652-122E5	122.48	13.43	1.02	0.81
Perineurial Cells, donor1	11499-119F5	121.61	13.68	1.13	0.23
Perineurial Cells, donor2	11579-120F4	91.55	7.54	0.92	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	93.39	4.46	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	60.97	5.88	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	67.04	5.18	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	29.42	3.59	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	80.95	22.18	5.54	1.11
Placental Epithelial Cells, donor3	11427-118G5	91.88	13.55	0.79	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	68.04	8.86	0.32	2.22
Preadipocyte - breast, donor1	11467-119B9	83.66	10.88	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	77.66	12.27	2.09	0.39
Preadipocyte - breast, donor2	11328-117E5	89.61	12.38	1.13	2.48
Preadipocyte - omental, donor1	11468-119C1	106.24	14.28	2.02	0.85
Preadipocyte - omental, donor2	11329-117E6	83.37	8.73	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	101.13	9.88	2.29	0.57
Preadipocyte - perirenal, donor1	11469-119C2	82.68	27.56	8.86	3.94
Preadipocyte - subcutaneous, donor1	11279-116I1	83.84	5.53	1.84	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	46.57	5.49	1.06	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	55.85	3.24	1.02	1.36
Preadipocyte - visceral, donor1	11280-116I2	48.25	2.24	1.02	0.28
Preadipocyte - visceral, donor2	11357-117H7	43.72	3.68	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	28.42	1.78	0.31	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	113.14	42.09	3.17	1.81
Prostate Epithelial Cells, donor2	11331-117E8	70.96	10.83	2.44	2.57
Prostate Epithelial Cells, donor3	11404-118D9	83.53	8.57	1.41	1.10
Prostate Stromal Cells, donor1	11254-116F3	52.74	6.15	0.91	0.34
Prostate Stromal Cells, donor2	11332-117E9	60.60	9.14	0.90	1.79
Prostate Stromal Cells, donor3	11405-118E1	99.37	12.83	1.36	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	266.07	47.81	1.46	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	144.38	17.95	1.73	0.35
Renal Epithelial Cells, donor1	11517-119H5	205.94	34.49	3.04	0.51
Renal Epithelial Cells, donor2	11597-120H4	123.77	17.07	2.85	1.42
Renal Epithelial Cells, donor3	11678-122H4	122.38	16.20	1.06	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	139.57	21.79	2.72	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	107.68	13.75	2.43	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	56.39	6.44	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	127.77	12.64	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	188.84	24.21	3.96	0.66
Renal Mesangial Cells, donor2	11598-120H5	159.25	40.13	3.76	2.51
Renal Mesangial Cells, donor3	11679-122H5	188.36	32.46	3.05	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	209.10	37.85	6.71	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	137.05	29.10	5.90	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	152.16	26.42	2.89	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	177.61	29.56	3.11	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	219.15	35.81	3.41	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	177.01	26.76	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	137.75	15.81	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	90.07	16.17	3.61	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	16.97	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.57	7.71	2.75	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	75.99	16.82	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	101.29	30.95	3.77	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	104.77	22.15	4.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	121.91	22.20	4.13	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	94.65	17.61	3.97	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	99.18	19.11	3.61	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	127.82	24.73	5.08	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	90.91	18.89	5.61	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	85.92	20.42	4.24	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	89.42	18.99	2.69	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	91.24	18.51	3.59	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	98.30	16.85	3.11	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	102.23	19.03	5.31	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	97.50	23.51	3.63	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	93.63	18.82	3.54	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	120.64	26.68	3.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	114.53	26.67	3.32	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	113.40	20.83	3.80	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	105.60	21.39	5.16	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	115.66	24.67	5.02	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	102.59	23.83	2.80	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	112.28	28.03	6.49	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	99.55	26.80	4.01	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	106.57	23.05	3.80	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	120.75	24.45	6.31	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	97.42	30.43	5.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	100.40	19.44	2.98	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	118.33	23.62	4.44	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	98.91	21.98	5.18	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	103.08	32.74	4.20	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	114.68	26.11	4.18	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	104.84	22.74	3.23	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	112.56	25.71	4.77	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	128.02	26.22	5.21	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	85.80	13.24	3.09	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.86	15.50	3.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	90.62	21.01	3.61	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	99.87	23.01	4.94	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	101.50	15.54	3.26	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	104.75	20.52	3.20	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	126.10	26.96	4.15	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	110.48	18.57	2.14	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	168.89	33.05	7.46	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	116.78	32.21	5.46	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	85.24	19.56	3.14	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	85.53	26.59	3.63	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	113.94	30.11	7.71	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	112.08	21.69	3.64	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	90.05	16.43	2.43	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	86.50	32.55	5.12	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	103.37	21.94	3.62	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	124.31	15.58	1.80	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	92.81	20.07	1.77	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	102.03	13.66	1.92	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.94	16.23	1.20	2.40
Schwann Cells, donor1	11498-119F4	144.25	13.73	1.88	1.50
Schwann Cells, donor2	11578-120F3	85.06	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	101.00	21.69	2.85	1.75
Sebocyte, donor1	11220-116B5	239.38	31.77	10.41	0.55
Sebocyte, donor2	11301-117B5	120.86	24.36	7.81	1.38
Sebocyte, donor3	11378-118B1	120.37	14.43	3.09	0.82
Sertoli Cells, donor1	11255-116F4	67.92	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	53.66	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	43.99	1.67	0.00	0.09
Skeletal Muscle Cells, donor2	11358-117H8	155.41	14.46	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	45.15	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	75.88	11.15	1.41	2.98
Skeletal Muscle Cells, donor5	11455-119A6	79.67	13.82	2.23	1.49
Skeletal Muscle Cells, donor6	11459-119B1	77.26	11.70	1.08	1.69
Skeletal Muscle Satellite Cells, donor1	11240-116D7	171.62	21.04	2.52	1.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	132.70	23.97	3.14	4.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	116.37	14.39	2.28	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	134.38	16.09	3.29	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	3.62	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	111.18	14.86	3.99	2.75
Skin - palm, donor1	10286-104F7	80.58	16.12	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	51.61	11.96	4.18	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	85.06	26.99	5.73	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	55.31	18.05	2.99	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	87.30	12.37	3.48	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	103.52	20.68	4.78	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	164.93	62.80	11.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	110.10	17.76	3.22	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	28.70	2.47	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	77.15	8.23	0.89	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	67.60	3.53	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	52.15	3.31	1.55	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	55.13	2.36	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	78.03	3.86	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	108.08	14.01	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	61.88	2.66	1.46	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	40.78	4.88	0.00	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	31.62	2.43	0.38	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	97.68	12.37	2.93	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	102.48	13.88	3.54	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	99.23	9.68	1.42	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	178.94	20.01	3.42	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	138.52	10.35	2.13	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	69.20	4.55	1.26	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	63.90	5.72	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	93.65	11.95	1.47	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	95.14	15.93	2.15	3.66
Smooth Muscle Cells - Colonic, donor3	11396-118D1	98.03	13.85	1.78	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	56.77	3.25	0.93	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	40.96	3.23	0.00	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.47	1.79	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	190.84	17.75	1.71	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	180.46	21.05	1.18	0.55
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	50.92	3.32	0.81	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	35.73	2.73	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	48.30	9.06	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	50.07	4.77	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	80.83	12.78	1.73	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	98.80	14.40	2.38	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	116.18	18.26	4.57	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	68.30	4.82	0.45	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	44.26	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	93.04	37.47	38.77	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	73.95	3.72	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	37.36	2.02	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.99	1.88	0.94	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	122.72	10.62	2.95	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	93.97	12.16	2.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	144.82	18.69	1.87	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	49.51	1.30	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	51.25	5.10	0.76	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	64.87	6.96	0.94	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	110.96	12.86	2.10	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	116.38	11.48	1.01	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	98.09	5.24	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	51.62	2.94	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	74.46	7.51	1.33	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	86.31	12.87	1.46	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	65.50	3.69	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	67.70	6.88	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	19.34	7.44	0.00	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	61.81	3.95	0.36	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	42.02	4.26	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.78	3.15	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	26.92	2.79	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	33.54	1.60	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	48.07	5.02	0.84	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	77.92	8.71	1.38	0.92
Synoviocyte, donor1	11291-117A4	36.36	4.54	0.84	0.17
Synoviocyte, donor2	11368-117I9	38.39	3.52	0.17	0.17
Synoviocyte, donor3	11440-118H9	39.77	2.90	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	180.09	25.37	2.86	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	172.44	13.87	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	168.80	23.15	3.47	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	121.15	14.48	3.23	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	89.68	24.35	4.25	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	83.04	13.17	4.01	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	104.08	17.22	3.94	0.37
Urethra, donor2	10319-105A4	57.55	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	142.13	17.00	3.72	0.27
Urothelial Cells, donor2	11600-120H7	110.56	16.82	3.20	2.00
Urothelial Cells, donor3	11681-122H7	115.06	23.15	2.75	1.38
Urothelial cells, donor0	11216-116B1	137.53	11.37	1.34	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	64.95	2.67	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	74.34	8.58	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	44.49	4.11	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.26	5.17	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	58.68	5.23	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	48.94	2.08	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	63.33	5.51	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	46.56	2.74	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	88.33	14.68	2.84	0.74
Wilms' tumor cell line:HFWT	10597-108E3	99.44	22.00	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	84.35	10.06	1.12	0.56
achilles tendon, donor2	10292-104G4	45.46	0.00	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	209.06	52.52	6.63	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	210.12	14.16	1.16	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	284.54	88.32	9.85	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	107.21	23.13	5.71	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	174.83	21.36	1.12	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	88.19	3.60	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	307.87	37.29	3.27	5.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	192.12	15.86	1.76	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	323.42	43.69	2.45	2.86
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	154.93	16.31	3.49	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	122.91	9.94	0.55	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	261.33	42.91	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	92.72	11.15	0.93	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	148.35	18.12	1.29	1.29
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	127.42	14.03	2.92	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	198.92	39.04	5.58	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	150.52	18.92	0.41	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	128.00	17.50	2.46	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	100.70	7.25	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	140.73	14.56	1.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	136.24	9.15	1.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	100.90	10.02	1.56	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	107.40	11.67	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	169.10	57.60	9.29	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	126.18	20.72	1.13	1.88
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	264.73	31.84	2.62	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	166.83	33.74	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	157.08	58.17	22.37	0.24
adipose tissue, adult, pool1	10010-101C1	56.15	3.41	0.16	0.62
adipose, donor1	10184-103D4	126.08	9.97	0.59	5.28
adipose, donor2	10185-103D5	66.10	10.14	0.81	2.03
adipose, donor3	10186-103D6	77.06	11.98	0.82	1.91
adipose, donor4	10187-103D7	73.67	9.53	0.87	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	95.95	4.89	0.79	0.00
adrenal gland, adult, pool1	10081-102A9	130.96	25.46	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	126.20	9.47	1.07	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	37.87	2.50	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	37.10	4.41	1.16	0.00
amniotic membrane cells, donor2	12236-129G4	20.96	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	16.20	1.18	0.00	0.00
amygdala - adult, donor10196	10167-103B5	264.43	23.72	3.56	1.19
amygdala, adult, donor10252	10151-102I7	210.27	15.21	1.62	1.62
amygdala, newborn, donor10223	10360-105E9	98.77	13.23	2.58	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	109.25	4.07	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	98.62	6.62	1.10	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	181.72	5.68	0.67	0.67
aorta, adult, pool1	10052-101G7	77.47	7.65	0.20	0.98
appendix, adult	10189-103D9	130.80	29.89	5.43	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	131.73	14.45	1.03	0.00
artery, adult	10190-103E1	44.84	12.23	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	177.03	15.21	1.01	0.43
b cell line:RPMI1788	10427-106D4	218.59	21.12	2.68	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.38	5.55	0.28	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	93.87	9.23	1.59	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	94.74	21.26	5.36	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	135.89	6.71	1.68	0.56
bladder, adult, pool1	10011-101C2	92.24	7.60	0.65	0.22
blood, adult, pool1	10053-101G8	33.22	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	100.19	14.56	2.57	0.00
bone marrow, adult	10192-103E3	43.19	5.40	0.00	0.67
brain, adult, donor1	10084-102B3	212.19	23.58	3.08	3.08
brain, adult, pool1	10012-101C3	236.86	20.49	1.56	0.78
brain, fetal, pool1	10085-102B4	277.83	40.07	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	93.82	19.82	3.30	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	276.86	169.01	35.70	0.25
breast, adult, donor1	10080-102A8	47.98	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	53.10	4.83	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	135.44	8.35	1.24	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	59.63	12.20	2.53	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	72.14	7.50	1.21	0.48
carcinoid cell line:NCI-H1770	10703-109H1	190.42	18.81	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	108.18	18.16	2.08	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	188.24	20.60	2.22	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	167.43	18.63	1.86	2.13
caudate nucleus - adult, donor10196	10177-103C6	194.57	20.72	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	165.15	7.86	1.00	0.67
caudate nucleus, adult, donor10258	10379-105H1	200.20	12.99	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	70.32	5.13	2.20	1.10
cerebellum - adult, donor10196	10173-103C2	308.81	26.22	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	337.35	16.44	0.43	4.27
cerebellum, adult, pool1	10083-102B2	158.67	15.18	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	195.12	11.62	3.32	3.32
cerebral meninges, adult	10188-103D8	197.17	10.09	1.51	0.76
cerebrospinal fluid, donor2	10294-104G6	56.28	2.92	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	70.31	10.64	0.58	0.14
cervical cancer cell line:ME-180	10553-107I4	78.72	13.92	1.66	0.33
cervix, adult, pool1	10013-101C4	115.49	16.17	1.99	0.52
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	44.45	3.90	0.56	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	108.42	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	190.89	10.07	0.87	0.50
choriocarcinoma cell line:SCH	10785-110H2	155.49	16.26	3.20	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	134.48	5.93	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	45.30	3.99	1.14	0.00
chorionic membrane cells, donor2	12239-129G7	46.43	3.58	0.00	0.00
chorionic membrane cells, donor3	12240-129G8	43.96	3.30	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	45.44	13.13	1.01	2.02
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	130.43	15.75	1.73	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	147.62	30.20	3.80	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	108.37	29.02	2.31	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	109.33	25.16	0.97	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	120.74	32.17	3.26	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	107.18	24.73	0.88	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	146.99	31.01	3.39	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	208.01	24.69	1.83	6.17
clear cell carcinoma cell line:TEN	10636-108I6	100.11	7.81	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	105.07	30.57	4.21	0.37
colon carcinoma cell line:COLO-320	10420-106C6	327.63	30.41	2.66	2.28
colon, adult, donor1	10082-102B1	97.58	41.65	13.09	2.38
colon, adult, pool1	10014-101C5	103.05	19.86	2.00	0.00
colon, fetal, donor1	10070-101I7	38.93	8.03	3.09	0.62
common myeloid progenitor CMP, donor1	12130-128D6	293.35	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	200.14	26.77	5.52	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	143.23	15.70	4.08	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	171.05	16.78	7.61	1.41
corpus callosum, adult, pool1	10042-101F6	221.79	54.84	4.20	0.33
cruciate ligament, donor2	10295-104G7	55.11	7.29	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	60.19	6.42	0.80	0.00
diencephalon, adult	10193-103E4	99.84	12.72	0.72	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	185.07	47.76	5.51	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	133.86	5.39	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	65.96	13.00	2.17	0.24
ductus deferens, adult	10196-103E7	142.53	12.46	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	8.64	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	79.45	18.39	1.47	0.74
dura mater, adult, donor1	10041-101F5	80.44	5.53	0.25	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	94.60	21.10	2.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	82.97	23.79	1.43	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	61.66	3.08	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	72.35	6.05	1.21	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.72	2.16	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	59.11	5.25	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	69.05	7.04	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	77.93	3.44	0.91	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	110.64	14.47	2.57	2.25
epidermoid carcinoma cell line:A431	10426-106D3	174.85	42.68	5.67	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	108.34	11.55	0.77	0.11
epididymis, adult	10197-103E8	114.70	9.21	2.30	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	51.45	5.68	1.60	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	66.46	11.40	2.75	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	85.05	17.30	2.88	1.70
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	91.83	18.60	3.44	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.77	17.59	3.02	1.23
esophagus, adult, pool1	10015-101C6	131.55	33.13	11.89	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	125.61	29.68	2.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	101.41	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	69.44	6.31	2.10	0.00
eye - muscle medial, donor2	10299-104H2	117.57	4.46	0.00	0.00
eye - muscle superior, donor2	10297-104G9	112.36	9.17	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	5.83	1.46	0.00
eye, fetal, donor1	10054-101G9	79.58	7.88	0.51	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	105.02	6.41	1.15	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	41.31	3.09	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	316.28	22.80	2.35	0.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	102.99	23.72	3.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	143.74	44.90	4.66	0.46
gall bladder, adult	10198-103E9	161.76	19.80	4.10	1.69
gamma delta positive T cells, donor1	11937-126A2	68.18	6.44	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	64.61	7.47	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.95	7.18	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	82.78	17.99	3.29	0.19
gastric cancer cell line:AZ521	10549-107H9	168.22	19.67	6.72	0.00
gastric cancer cell line:GSS	10560-108A2	155.59	13.73	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	155.58	76.08	6.17	2.97
giant cell carcinoma cell line:LU65	10487-107B1	77.79	6.65	0.46	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	106.79	13.44	1.82	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	128.95	14.22	3.49	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	61.96	13.62	2.96	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.89	11.09	2.53	0.42
glioblastoma cell line:T98G	10485-107A8	102.10	14.24	1.55	0.33
glioma cell line:GI-1	10413-106B8	132.38	5.56	2.05	0.88
globus pallidus - adult, donor10196	10175-103C4	107.88	8.75	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	144.75	15.38	0.73	0.98
globus pallidus, adult, donor10258	10367-105F7	87.63	10.95	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	90.06	13.86	2.13	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	367.07	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	50.24	5.44	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	82.18	15.61	1.84	1.38
hIPS +CCl2, biol_rep2	14384-156C1	85.97	22.86	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	70.21	18.03	2.58	1.93
hIPS, biol_rep1	14380-156B6	27.31	34.49	1.44	1.44
hIPS, biol_rep2	14381-156B7	46.64	14.40	1.37	0.69
hIPS, biol_rep3	14382-156B8	163.31	16.55	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	70.69	4.60	0.57	0.29
heart - mitral valve, adult	10205-103F7	81.62	12.26	1.49	0.60
heart - pulmonic valve, adult	10206-103F8	85.76	8.37	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	58.28	6.66	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	80.81	18.57	5.51	1.22
heart, adult, diseased, donor1	10051-101G6	70.69	6.39	0.00	1.70
heart, adult, pool1	10016-101C7	94.06	3.68	0.23	0.23
heart, fetal, pool1	10046-101G1	222.40	39.53	1.64	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	99.34	5.55	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	148.65	70.16	8.32	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	99.00	41.55	5.64	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	110.94	41.87	3.76	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	110.45	45.07	3.33	1.62
hepatoma cell line:Li-7	10484-107A7	62.73	22.47	1.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	137.38	12.76	1.61	0.40
hippocampus - adult, donor10196	10169-103B7	229.01	16.09	4.73	1.89
hippocampus, adult, donor10252	10153-102I9	192.26	13.47	1.02	1.02
hippocampus, adult, donor10258	10374-105G5	236.53	23.40	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	169.19	9.16	2.47	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	114.74	25.02	1.22	7.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	113.49	19.44	1.18	2.16
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	124.41	15.74	2.29	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	82.32	8.46	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	104.06	19.11	1.29	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	103.25	12.53	1.14	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	143.93	28.90	2.92	4.67
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	138.31	28.44	1.94	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	131.38	35.03	2.92	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	120.05	31.73	2.84	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	164.41	38.57	4.34	2.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	128.60	35.01	4.71	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	119.08	16.59	2.19	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	118.40	24.07	1.47	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	82.91	10.47	2.62	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	134.97	13.17	0.95	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	120.36	14.39	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	93.46	12.49	0.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	106.06	13.19	0.38	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	104.59	15.46	0.45	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	93.66	14.10	0.31	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	82.79	14.53	1.14	2.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	79.54	14.52	0.87	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	83.10	8.67	1.20	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	102.72	18.66	1.29	2.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	112.97	24.25	1.14	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	119.64	18.37	1.63	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	121.47	17.60	1.76	7.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	94.39	14.57	0.95	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	118.02	16.04	0.61	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	98.25	14.48	0.00	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	73.06	16.60	0.00	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	98.25	19.24	0.26	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	115.55	31.19	1.53	5.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	103.74	23.47	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	82.67	17.81	1.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	107.95	20.53	1.69	3.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	93.14	18.27	1.34	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	96.10	17.07	2.44	3.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	122.86	16.50	0.31	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	78.08	35.79	3.25	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	113.18	9.27	0.66	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	107.27	21.34	1.64	5.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	105.31	17.01	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	100.00	17.79	0.71	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	99.05	16.71	1.19	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	170.09	34.13	2.71	1.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	82.17	18.32	0.54	1.89
immature langerhans cells, donor1	11904-125F5	62.23	6.78	2.42	0.00
immature langerhans cells, donor2	11905-125F6	77.63	19.01	5.54	0.79
insula, adult, pool1	10039-101F3	423.58	26.88	3.60	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	63.73	5.20	4.23	0.00
kidney, adult, pool1	10017-101C8	113.74	12.12	1.30	0.40
kidney, fetal, pool1	10045-101F9	145.01	13.51	0.71	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.51	4.40	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	50.04	5.25	0.41	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	126.80	12.11	1.47	0.00
left atrium, adult, donor1	10079-102A7	46.86	3.81	0.54	1.09
left ventricle, adult, donor1	10078-102A6	34.38	1.52	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	57.73	20.52	3.56	0.00
leiomyoma cell line:10964C	10569-108B2	61.43	8.26	0.36	1.80
leiomyoma cell line:15242A	10570-108B3	31.52	2.17	1.09	1.63
leiomyoma cell line:15425	10571-108B4	38.36	3.89	0.97	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	96.19	6.27	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	107.91	13.10	1.65	0.00
liposarcoma cell line:KMLS-1	10782-110G8	45.93	1.87	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	79.32	10.48	1.71	0.12
liver, adult, pool1	10018-101C9	81.84	17.99	4.05	0.32
liver, fetal, pool1	10086-102B5	68.67	31.04	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	166.39	20.71	0.73	0.58
locus coeruleus, adult, donor10252	10165-103B3	164.62	15.50	0.92	1.29
locus coeruleus, adult, donor10258	10375-105G6	119.91	17.49	1.97	3.39
locus coeruleus, newborn, donor10223	10362-105F2	94.22	13.46	1.26	2.52
lung adenocarcinoma cell line:A549	10499-107C4	67.68	7.61	2.08	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	285.41	12.41	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	119.69	16.48	3.82	0.40
lung, adult, pool1	10019-101D1	128.64	23.03	2.72	0.24
lung, fetal, donor1	10068-101I5	143.27	24.83	2.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	78.35	15.58	2.29	0.92
lymph node, adult, donor1	10077-102A5	38.82	3.79	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	221.59	12.71	3.29	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	377.17	62.79	8.15	2.87
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.91	10.19	0.85	0.00
mature adipocyte, donor1	12231-129F8	84.36	7.10	0.89	0.00
mature adipocyte, donor2	12232-129F9	64.75	1.87	0.21	0.00
mature adipocyte, donor3	12233-129G1	39.59	1.90	0.00	0.00
mature adipocyte, donor4	12234-129G2	64.75	2.11	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	143.91	20.49	5.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	206.43	18.05	0.00	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	225.29	16.74	0.74	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	134.38	14.30	0.95	2.54
medial frontal gyrus, newborn, donor10223	10352-105E1	130.51	18.77	2.56	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	239.63	28.18	1.35	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	234.30	20.59	0.64	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	134.84	30.82	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	162.60	14.00	2.87	1.08
medulla oblongata - adult, donor10196	10174-103C3	105.78	18.17	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	148.30	18.27	0.62	0.93
medulla oblongata, adult, pool1	10038-101F2	202.68	35.18	3.10	0.08
medulla oblongata, newborn, donor10223	10361-105F1	88.88	10.42	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	167.17	18.60	1.77	1.99
medulloblastoma cell line:ONS-76	10759-110E3	49.77	4.65	0.49	0.00
melanoma cell line:COLO 679	10514-107E1	110.11	8.34	1.29	0.14
melanoma cell line:G-361	10465-106H6	120.26	4.34	0.54	0.81
meningioma cell line:HKBMM	10691-109F7	26.95	3.44	0.00	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	189.45	81.07	5.29	2.64
merkel cell carcinoma cell line:MS-1	10844-111E7	261.56	46.92	4.67	2.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	76.10	9.36	1.69	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	81.07	8.91	0.36	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	66.67	4.14	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	91.59	5.48	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	73.56	4.24	1.16	1.16
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	62.47	3.47	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	94.06	8.07	1.72	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	102.59	8.63	1.61	1.73
mesenchymal precursor cell - cardiac, donor3	11754-123G8	86.08	9.68	2.25	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	64.28	5.00	0.95	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	85.50	4.84	0.71	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	142.28	7.25	0.66	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	98.52	8.99	1.25	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	80.99	8.03	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	73.30	3.88	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	94.54	3.95	0.72	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	102.73	7.14	1.66	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	76.15	5.70	1.37	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.47	6.29	0.84	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	75.02	3.74	0.75	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	113.96	9.45	2.54	0.96
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	151.68	11.41	1.84	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	75.55	5.44	0.86	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.00	6.74	0.84	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	52.97	6.85	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	57.81	12.28	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	66.49	10.21	1.57	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	56.07	5.24	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	58.37	9.18	2.35	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	66.34	12.86	4.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	64.45	9.43	1.96	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	62.09	13.44	2.32	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	70.66	9.52	2.88	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	64.70	8.03	1.78	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	67.54	9.37	2.16	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	68.20	14.67	3.67	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	60.75	8.73	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	61.41	8.60	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	59.71	6.87	2.58	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	60.16	5.47	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	53.91	11.37	1.95	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	61.11	13.09	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	59.70	9.06	2.13	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	51.52	4.91	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	61.03	8.55	2.72	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	12.59	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	53.65	8.94	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	44.47	7.12	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	47.52	7.31	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	55.10	5.70	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	32.77	3.10	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.45	0.81	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	30.19	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.20	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	40.21	2.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	3.44	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	67.79	9.40	0.99	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	63.93	8.97	3.36	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	55.34	8.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.78	4.84	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	13.08	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	54.48	10.14	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	47.94	2.43	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	50.24	5.77	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.99	4.17	1.39	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	32.77	5.52	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	35.65	7.13	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	112.19	28.63	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	170.57	13.23	4.96	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	100.31	56.76	8.57	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	36.68	5.96	1.54	0.21
mesothelioma cell line:Mero-25	10850-111F4	92.37	12.03	1.13	1.13
mesothelioma cell line:Mero-41	10851-111F5	41.56	4.65	0.49	0.98
mesothelioma cell line:Mero-48a	10852-111F6	43.18	2.21	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	48.36	7.10	0.53	0.53
mesothelioma cell line:Mero-83	10854-111F8	31.66	5.11	0.85	0.17
mesothelioma cell line:Mero-84	10855-111F9	49.04	7.58	1.77	0.25
mesothelioma cell line:Mero-95	10856-111G1	8.49	1.04	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	78.35	6.63	1.49	0.50
mesothelioma cell line:NCI-H226	10846-111E9	23.89	6.33	0.90	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	52.44	17.77	4.44	0.51
mesothelioma cell line:NCI-H28	10845-111E8	62.85	10.94	1.78	1.53
mesothelioma cell line:No36	10857-111G2	50.56	17.94	2.28	0.33
mesothelioma cell line:ONE58	10858-111G3	67.47	19.51	3.52	0.27
migratory langerhans cells, donor1	11901-125F2	96.54	18.42	5.37	0.77
migratory langerhans cells, donor2	11902-125F3	199.54	30.65	6.11	0.49
migratory langerhans cells, donor3	11903-125F4	144.84	11.13	1.79	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	39.18	4.24	0.65	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	33.06	8.69	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	52.29	3.92	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	121.22	7.99	2.85	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	192.37	17.92	0.92	0.74
myeloma cell line:PCM6	10474-106I6	154.18	10.67	1.38	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	163.35	13.19	4.57	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	74.34	4.90	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	104.18	12.70	1.89	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	93.62	10.30	1.47	1.03
nasal epithelial cells, donor2	12227-129F4	120.89	15.46	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	239.26	34.74	1.38	0.23
neuroblastoma cell line:NB-1	10539-107G8	295.59	63.80	6.17	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	208.15	20.46	2.53	2.11
neuroblastoma cell line:NH-12	10555-107I6	232.94	23.29	0.75	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	124.31	23.96	1.19	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	97.40	9.34	0.79	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	192.40	27.37	2.21	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	183.10	36.87	5.09	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	53.77	3.73	2.13	0.00
neutrophil PMN, donor1	12133-128D9	297.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	253.68	33.99	0.34	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	45.63	16.81	2.40	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.92	7.05	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	44.93	7.36	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	303.62	23.53	3.19	0.66
occipital cortex - adult, donor10196	10172-103C1	253.43	20.60	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	248.50	14.49	0.54	1.07
occipital cortex, newborn, donor10223	10355-105E4	199.44	22.93	2.55	0.36
occipital lobe, adult, donor1	10076-102A4	247.44	22.57	3.41	2.10
occipital lobe, fetal, donor1	10073-102A1	335.56	41.62	8.15	3.00
occipital pole, adult, pool1	10036-101E9	340.20	22.94	3.15	0.47
olfactory region, adult	10195-103E6	233.66	17.77	2.10	0.96
optic nerve, donor1	10277-104E7	174.09	28.01	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	124.27	8.32	1.82	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	108.54	21.57	1.37	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	106.34	25.57	2.20	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	83.28	6.93	0.35	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	48.80	4.12	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	233.58	9.34	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	170.92	99.88	8.91	0.42
ovary, adult, pool1	10020-101D2	124.04	7.95	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	99.91	8.62	0.55	0.55
pancreas, adult, donor1	10049-101G4	80.89	6.58	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	117.13	3.91	1.12	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	75.81	10.73	0.68	1.19
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	161.44	17.22	1.99	0.00
paracentral gyrus, adult, pool1	10035-101E8	312.64	25.35	2.47	0.64
parietal cortex, adult, donor10258	10373-105G4	149.00	15.41	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	227.60	16.93	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	210.07	15.11	0.86	0.86
parietal lobe, adult, pool1	10034-101E7	313.79	25.29	2.03	0.26
parietal lobe, fetal, donor1	10072-101I9	288.04	37.82	8.73	3.88
parietal lobe, newborn, donor10223	10356-105E5	167.49	17.95	3.36	0.75
parotid gland, adult	10199-103F1	98.05	8.63	0.62	1.23
penis, adult	10200-103F2	81.10	16.65	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	198.95	26.96	2.05	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	66.00	6.41	1.46	0.29
pineal gland - adult, donor10196	10179-103C8	146.42	7.10	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	192.47	10.07	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	136.08	10.66	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	116.36	8.09	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	143.85	4.69	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	70.65	3.40	0.00	0.85
placenta, adult, pool1	10021-101D3	68.37	5.91	0.54	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	188.31	15.63	1.72	2.38
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	137.59	28.33	2.02	0.00
pons, adult, pool1	10033-101E6	203.46	27.28	3.53	0.34
postcentral gyrus, adult, pool1	10032-101E5	342.95	26.50	3.14	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	376.45	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	106.92	12.53	3.20	0.58
prostate cancer cell line:PC-3	10439-106E7	75.32	9.08	1.09	0.00
prostate, adult, pool1	10022-101D4	93.96	6.98	0.63	0.18
putamen, adult, donor10196	10176-103C5	223.55	17.94	1.65	2.36
putamen, adult, donor10252	10152-102I8	147.05	7.84	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	62.29	25.13	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	201.99	12.32	1.45	0.48
putamen, newborn, donor10223	10365-105F5	45.73	11.99	3.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	128.59	9.89	1.75	0.00
rectum, fetal, donor1	10067-101I4	134.93	9.74	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	105.79	9.75	1.06	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	52.60	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	192.74	17.69	0.70	0.30
retinoblastoma cell line:Y79	10475-106I7	156.92	22.86	0.78	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	70.33	4.67	0.61	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	78.45	5.91	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	106.10	3.03	0.00	0.00
salivary acinar cells, donor1	11771-123I7	111.84	16.19	3.08	0.16
salivary acinar cells, donor2	11772-123I8	83.85	6.88	2.34	0.96
salivary acinar cells, donor3	11773-123I9	123.80	25.16	13.24	0.00
salivary gland, adult, pool1	10093-102C3	167.01	18.87	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	44.18	1.52	0.25	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	41.73	1.29	0.24	0.12
seminal vesicle, adult	10201-103F3	129.09	11.11	0.00	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	101.54	26.24	2.92	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	91.85	25.92	3.27	1.76
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	62.22	11.04	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	144.66	11.01	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	181.38	71.84	10.39	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	108.12	52.13	16.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	48.94	4.26	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	62.73	2.28	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	62.31	8.04	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	13.57	6.79	0.00
skin, fetal, donor1	10065-101I2	89.63	10.73	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	249.81	63.70	19.34	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	152.56	40.66	2.21	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	97.53	7.52	1.35	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	163.67	24.06	5.11	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	417.40	37.32	1.61	3.54
small cell lung carcinoma cell line:WA-hT	10562-108A4	144.48	33.34	3.05	0.44
small intestine, adult, pool1	10024-101D6	153.01	26.52	4.54	0.24
small intestine, fetal, donor1	10064-101I1	59.95	4.67	0.25	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	83.09	17.95	2.05	3.08
smooth muscle, adult, pool1	10048-101G3	86.84	4.91	0.52	1.03
somatostatinoma cell line:QGP-1	10781-110G7	102.12	23.85	5.90	0.00
spinal cord - adult, donor10196	10181-103D1	124.80	16.29	2.75	0.23
spinal cord, adult, donor10252	10159-103A6	91.87	11.43	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	83.71	22.83	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	197.59	34.15	1.83	2.44
spinal cord, newborn, donor10223	10359-105E8	94.14	9.18	2.76	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	53.92	4.33	0.60	0.30
spleen, adult, pool1	10025-101D7	88.22	4.41	0.55	0.11
spleen, fetal, pool1	10044-101F8	94.79	7.15	0.32	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	147.09	16.04	3.11	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	54.11	6.27	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	102.74	42.98	9.44	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	33.62	1.56	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	63.60	5.85	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	53.37	9.32	1.69	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	136.23	45.69	13.96	0.85
stomach, fetal, donor1	10062-101H8	112.14	14.95	3.20	0.00
submaxillary gland, adult	10202-103F4	116.78	9.68	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	111.12	11.22	0.21	1.25
substantia nigra, adult, donor10258	10371-105G2	150.00	26.90	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	81.96	8.48	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	171.03	25.91	5.73	1.15
temporal lobe, adult, pool1	10031-101E4	389.35	33.48	3.22	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	348.30	34.19	5.70	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	315.15	58.02	7.91	3.52
tenocyte, donor1	11763-123H8	64.58	8.03	1.40	1.05
tenocyte, donor2	11765-123I1	49.60	3.82	0.38	1.53
tenocyte, donor3	11768-123I4	41.51	6.30	0.37	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	88.21	22.94	2.89	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	127.33	14.80	1.54	0.77
teratocarcinoma cell line:PA-1	10807-111A6	178.22	17.36	1.86	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	125.55	24.37	3.17	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	85.09	7.56	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	47.11	5.89	0.33	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	82.73	8.47	0.33	1.30
testis, adult, pool1	10026-101D8	95.88	12.24	1.93	0.86
testis, adult, pool2	10096-102C6	120.44	20.75	3.61	1.80
thalamus - adult, donor10196	10168-103B6	168.91	27.60	2.21	1.10
thalamus, adult, donor10252	10154-103A1	155.50	22.19	0.47	2.19
thalamus, adult, donor10258, tech_rep1	10370-105G1	87.76	20.02	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	91.40	12.52	0.99	1.32
thalamus, newborn, donor10223	10366-105F6	85.72	13.23	1.15	1.15
throat, adult	10209-103G2	84.39	17.98	3.25	0.25
throat, fetal, donor1	10061-101H7	56.37	5.79	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	134.94	21.07	1.79	0.60
thymus, adult, pool1	10027-101D9	101.60	9.25	0.70	0.30
thymus, fetal, pool1	10043-101F7	110.35	7.27	1.04	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	33.64	3.32	0.00	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	81.58	6.57	0.98	0.28
thyroid, adult, pool1	10028-101E1	94.34	4.57	0.47	0.28
thyroid, fetal, donor1	10060-101H6	55.11	3.95	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	98.55	9.24	0.00	0.00
tongue, adult	10203-103F5	85.36	24.19	9.30	2.79
tongue, fetal, donor1	10059-101H5	59.51	10.64	1.97	1.97
tonsil, adult, pool1	10047-101G2	165.69	33.76	8.62	0.20
trachea, adult, pool1	10029-101E2	106.67	18.81	5.48	0.33
trachea, fetal, donor1	10058-101H4	68.86	12.69	2.31	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	25.86	1.42	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	156.74	16.11	1.62	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	145.25	11.44	1.88	0.78
tridermal teratoma cell line:HGRT	10694-109G1	81.81	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	56.80	6.01	0.59	0.25
umbilical cord, fetal, donor1	10057-101H3	60.51	12.52	4.17	0.00
uterus, adult, pool1	10100-102D1	98.62	9.21	0.85	0.00
uterus, fetal, donor1	10055-101H1	101.36	12.29	3.58	0.51
vagina, adult	10204-103F6	84.01	9.05	0.00	0.00
vein, adult	10191-103E2	74.31	10.30	1.10	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	153.81	15.49	0.80	0.80